date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.473753483655928.
The log-likelihood improved by 5.4.
Iteration 2 of at most 500:
Optimizing with step length 0.840595122325777.
The log-likelihood improved by 2.878.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.3301.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.6859.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       1       28     1219     1006      793      364      390      331 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     306      202      161      100       56       24       16        2 
degree17 
       1 
1 
disease_progression 
H-positive risk:  827 906 126 853 434 130 942 418 122 61 114 67 
H-negative risk:  906 827 942 853 418 434 130 126 114 122 67 61 
New BC onsets:  1
BC status:  4999 1 
BC subtype:  4999 1 

clinical_engagement 
diagnosis 
demography 
63 new agents 
2 
disease_progression 
H-positive risk:  825 910 129 856 432 131 940 412 125 60 113 67 
H-negative risk:  910 825 940 856 412 432 131 129 113 125 67 60 
New BC onsets:  4
BC status:  4996 4 
BC subtype:  4996 4 

clinical_engagement 
diagnosis 
demography 
56 new agents 
3 
disease_progression 
H-positive risk:  829 911 131 855 425 134 941 406 127 60 114 67 
H-negative risk:  911 829 941 855 406 425 134 131 114 127 67 60 
New BC onsets:  9
BC status:  4991 9 
BC subtype:  4991 8 1 

clinical_engagement 
diagnosis 
demography 
68 new agents 
4 
disease_progression 
H-positive risk:  833 914 131 860 424 136 931 403 127 61 113 67 
H-negative risk:  914 833 931 860 403 424 136 131 113 127 67 61 
New BC onsets:  13
BC status:  4987 13 
BC subtype:  4987 11 2 

clinical_engagement 
diagnosis 
demography 
55 new agents 
5 
disease_progression 
H-positive risk:  833 920 131 862 424 134 928 401 128 60 112 67 
H-negative risk:  920 833 928 862 401 424 134 131 112 128 67 60 
New BC onsets:  14
BC status:  4986 14 
BC subtype:  4986 12 2 

clinical_engagement 
diagnosis 
demography 
59 new agents 
6 
disease_progression 
H-positive risk:  842 923 130 858 420 136 927 397 130 59 113 65 
H-negative risk:  923 842 927 858 397 420 136 130 113 130 65 59 
New BC onsets:  19
BC status:  4981 19 
BC subtype:  4981 16 3 

clinical_engagement 
diagnosis 
demography 
61 new agents 
7 
disease_progression 
H-positive risk:  842 923 131 866 418 136 923 395 128 60 114 64 
H-negative risk:  923 842 923 866 395 418 136 131 114 128 64 60 
New BC onsets:  20
BC status:  4980 20 
BC subtype:  4980 17 3 

clinical_engagement 
diagnosis 
demography 
58 new agents 
8 
disease_progression 
H-positive risk:  844 933 130 864 413 136 923 392 130 58 112 65 
H-negative risk:  933 844 923 864 392 413 136 130 112 130 65 58 
New BC onsets:  25
BC status:  4975 25 
BC subtype:  4975 21 4 

clinical_engagement 
diagnosis 
demography 
49 new agents 
9 
disease_progression 
H-positive risk:  849 934 130 860 405 138 926 388 130 59 116 65 
H-negative risk:  934 849 926 860 388 405 138 130 116 130 65 59 
New BC onsets:  27
BC status:  4973 27 
BC subtype:  4973 23 4 

clinical_engagement 
diagnosis 
demography 
65 new agents 
10 
disease_progression 
H-positive risk:  855 942 130 859 398 140 924 381 131 59 115 66 
H-negative risk:  942 855 924 859 381 398 140 130 115 131 66 59 
New BC onsets:  28
BC status:  4972 28 
BC subtype:  4972 24 4 

clinical_engagement 
diagnosis 
demography 
55 new agents 
11 
disease_progression 
H-positive risk:  860 955 130 857 401 140 921 373 128 56 113 66 
H-negative risk:  955 860 921 857 373 401 140 130 113 128 66 56 
New BC onsets:  31
BC status:  4969 31 
BC subtype:  4969 26 5 

clinical_engagement 
diagnosis 
demography 
54 new agents 
12 
disease_progression 
H-positive risk:  862 955 129 862 403 140 919 370 124 57 113 66 
H-negative risk:  955 862 919 862 370 403 140 129 113 124 66 57 
New BC onsets:  31
BC status:  4969 31 
BC subtype:  4969 26 5 

clinical_engagement 
diagnosis 
demography 
54 new agents 
13 
disease_progression 
H-positive risk:  799 879 115 939 405 123 980 368 142 57 126 67 
H-negative risk:  879 799 980 939 368 405 123 115 126 142 67 57 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 26 6 

clinical_engagement 
diagnosis 
demography 
219 new agents 
14 
disease_progression 
H-positive risk:  844 899 119 872 421 126 924 407 142 53 128 65 
H-negative risk:  899 844 924 872 407 421 126 119 128 142 65 53 
New BC onsets:  34
BC status:  4966 34 
BC subtype:  4966 29 5 

clinical_engagement 
diagnosis 
demography 
67 new agents 
15 
disease_progression 
H-positive risk:  848 902 122 876 404 126 922 407 143 55 129 66 
H-negative risk:  902 848 922 876 407 404 126 122 129 143 66 55 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 29 6 

clinical_engagement 
diagnosis 
demography 
56 new agents 
16 
disease_progression 
H-positive risk:  854 902 121 881 404 125 914 404 145 56 128 66 
H-negative risk:  902 854 914 881 404 404 125 121 128 145 66 56 
New BC onsets:  37
BC status:  4963 37 
BC subtype:  4963 30 7 

clinical_engagement 
diagnosis 
demography 
64 new agents 
17 
disease_progression 
H-positive risk:  858 906 120 881 399 126 915 401 142 55 130 67 
H-negative risk:  906 858 915 881 401 399 126 120 130 142 67 55 
New BC onsets:  39
BC status:  4961 39 
BC subtype:  4961 30 9 

clinical_engagement 
diagnosis 
demography 
52 new agents 
18 
disease_progression 
H-positive risk:  862 904 121 879 396 128 913 402 144 56 129 66 
H-negative risk:  904 862 913 879 402 396 128 121 129 144 66 56 
New BC onsets:  39
BC status:  4961 39 
BC subtype:  4961 30 9 

clinical_engagement 
diagnosis 
demography 
72 new agents 
19 
disease_progression 
H-positive risk:  873 906 122 874 396 130 899 407 141 57 131 64 
H-negative risk:  906 873 899 874 407 396 130 122 131 141 64 57 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 32 10 

clinical_engagement 
diagnosis 
demography 
58 new agents 
20 
disease_progression 
H-positive risk:  879 915 122 869 392 129 896 404 141 59 132 62 
H-negative risk:  915 879 896 869 404 392 129 122 132 141 62 59 
New BC onsets:  43
BC status:  4957 43 
BC subtype:  4957 33 10 

clinical_engagement 
diagnosis 
demography 
61 new agents 
21 
disease_progression 
H-positive risk:  879 922 121 869 384 130 898 403 141 58 131 64 
H-negative risk:  922 879 898 869 403 384 130 121 131 141 64 58 
New BC onsets:  44
BC status:  4956 44 
BC subtype:  4956 34 10 

clinical_engagement 
diagnosis 
demography 
77 new agents 
22 
disease_progression 
H-positive risk:  884 935 120 865 380 133 903 391 145 55 128 61 
H-negative risk:  935 884 903 865 391 380 133 120 128 145 61 55 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 37 10 

clinical_engagement 
diagnosis 
demography 
58 new agents 
23 
disease_progression 
H-positive risk:  883 938 120 865 378 133 906 388 143 55 129 62 
H-negative risk:  938 883 906 865 388 378 133 120 129 143 62 55 
New BC onsets:  49
BC status:  4951 49 
BC subtype:  4951 39 10 

clinical_engagement 
diagnosis 
demography 
68 new agents 
24 
disease_progression 
H-positive risk:  889 946 120 857 372 132 914 386 143 56 126 59 
H-negative risk:  946 889 914 857 386 372 132 120 126 143 59 56 
New BC onsets:  50
BC status:  4950 50 
BC subtype:  4950 40 10 

clinical_engagement 
diagnosis 
demography 
52 new agents 
25 
disease_progression 
H-positive risk:  820 884 103 924 373 123 984 382 154 55 139 59 
H-negative risk:  884 820 984 924 382 373 123 103 139 154 59 55 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 40 15 

clinical_engagement 
diagnosis 
demography 
162 new agents 
26 
disease_progression 
H-positive risk:  858 906 102 881 392 126 935 409 145 53 130 63 
H-negative risk:  906 858 935 881 409 392 126 102 130 145 63 53 
New BC onsets:  56
BC status:  4944 56 
BC subtype:  4944 39 17 

clinical_engagement 
diagnosis 
demography 
70 new agents 
27 
disease_progression 
H-positive risk:  868 913 100 879 387 126 938 401 141 53 132 62 
H-negative risk:  913 868 938 879 401 387 126 100 132 141 62 53 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 38 17 

clinical_engagement 
diagnosis 
demography 
58 new agents 
28 
disease_progression 
H-positive risk:  868 918 101 880 384 125 938 397 143 54 131 61 
H-negative risk:  918 868 938 880 397 384 125 101 131 143 61 54 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 41 17 

clinical_engagement 
diagnosis 
demography 
72 new agents 
29 
disease_progression 
H-positive risk:  870 925 103 879 380 127 937 394 139 54 131 61 
H-negative risk:  925 870 937 879 394 380 127 103 131 139 61 54 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 45 17 

clinical_engagement 
diagnosis 
demography 
67 new agents 
30 
disease_progression 
H-positive risk:  878 925 101 885 374 128 940 387 136 55 131 60 
H-negative risk:  925 878 940 885 387 374 128 101 131 136 60 55 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 45 17 

clinical_engagement 
diagnosis 
demography 
62 new agents 
31 
disease_progression 
H-positive risk:  881 930 99 882 376 128 932 388 135 55 132 62 
H-negative risk:  930 881 932 882 388 376 128 99 132 135 62 55 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 47 18 

clinical_engagement 
diagnosis 
demography 
80 new agents 
32 
disease_progression 
H-positive risk:  883 937 101 886 375 124 934 382 134 53 130 61 
H-negative risk:  937 883 934 886 382 375 124 101 130 134 61 53 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 45 18 

clinical_engagement 
diagnosis 
demography 
55 new agents 
33 
disease_progression 
H-positive risk:  888 936 102 889 372 124 930 380 134 55 131 59 
H-negative risk:  936 888 930 889 380 372 124 102 131 134 59 55 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 45 19 

clinical_engagement 
diagnosis 
demography 
67 new agents 
34 
disease_progression 
H-positive risk:  888 939 103 893 373 121 924 378 137 54 131 59 
H-negative risk:  939 888 924 893 378 373 121 103 131 137 59 54 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 48 19 

clinical_engagement 
diagnosis 
demography 
61 new agents 
35 
disease_progression 
H-positive risk:  894 941 104 887 373 120 919 384 133 56 131 58 
H-negative risk:  941 894 919 887 384 373 120 104 131 133 58 56 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 49 21 

clinical_engagement 
diagnosis 
demography 
54 new agents 
36 
disease_progression 
H-positive risk:  892 937 106 884 370 122 923 388 133 58 128 59 
H-negative risk:  937 892 923 884 388 370 122 106 128 133 59 58 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 49 21 

clinical_engagement 
diagnosis 
demography 
63 new agents 
37 
disease_progression 
H-positive risk:  850 873 100 944 367 111 975 385 146 57 136 56 
H-negative risk:  873 850 975 944 385 367 111 100 136 146 56 57 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 52 22 

clinical_engagement 
diagnosis 
demography 
150 new agents 
38 
disease_progression 
H-positive risk:  857 893 101 922 389 112 961 379 140 53 136 57 
H-negative risk:  893 857 961 922 379 389 112 101 136 140 57 53 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 56 19 

clinical_engagement 
diagnosis 
demography 
61 new agents 
39 
disease_progression 
H-positive risk:  863 892 100 919 399 115 950 377 138 52 136 59 
H-negative risk:  892 863 950 919 377 399 115 100 136 138 59 52 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 60 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
40 
disease_progression 
H-positive risk:  872 897 100 915 389 117 943 385 137 52 133 60 
H-negative risk:  897 872 943 915 385 389 117 100 133 137 60 52 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 63 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
41 
disease_progression 
H-positive risk:  873 897 101 915 387 119 951 379 134 49 136 59 
H-negative risk:  897 873 951 915 379 387 119 101 136 134 59 49 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 62 22 

clinical_engagement 
diagnosis 
demography 
62 new agents 
42 
disease_progression 
H-positive risk:  873 896 99 911 385 121 955 380 132 51 137 60 
H-negative risk:  896 873 955 911 380 385 121 99 137 132 60 51 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 63 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
43 
disease_progression 
H-positive risk:  875 901 99 907 383 125 955 379 130 49 139 58 
H-negative risk:  901 875 955 907 379 383 125 99 139 130 58 49 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 67 21 

clinical_engagement 
diagnosis 
demography 
68 new agents 
44 
disease_progression 
H-positive risk:  877 909 99 911 380 126 955 375 127 47 136 58 
H-negative risk:  909 877 955 911 375 380 126 99 136 127 58 47 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 69 23 

clinical_engagement 
diagnosis 
demography 
61 new agents 
45 
disease_progression 
H-positive risk:  882 912 100 909 378 128 951 370 124 48 139 59 
H-negative risk:  912 882 951 909 370 378 128 100 139 124 59 48 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 70 23 

clinical_engagement 
diagnosis 
demography 
60 new agents 
46 
disease_progression 
H-positive risk:  883 909 102 902 385 128 953 369 124 48 137 60 
H-negative risk:  909 883 953 902 369 385 128 102 137 124 60 48 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 69 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
47 
disease_progression 
H-positive risk:  883 916 101 904 379 129 952 366 124 48 139 59 
H-negative risk:  916 883 952 904 366 379 129 101 139 124 59 48 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 69 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
48 
disease_progression 
H-positive risk:  888 919 101 907 375 130 955 363 123 49 134 56 
H-negative risk:  919 888 955 907 363 375 130 101 134 123 56 49 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
61 new agents 
49 
disease_progression 
H-positive risk:  830 857 93 973 373 126 1013 366 127 49 139 54 
H-negative risk:  857 830 1013 973 366 373 126 93 139 127 54 49 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
150 new agents 
50 
disease_progression 
H-positive risk:  848 877 95 961 371 127 967 389 122 54 134 55 
H-negative risk:  877 848 967 961 389 371 127 95 134 122 55 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
51 
disease_progression 
H-positive risk:  856 873 99 956 369 128 965 390 121 54 132 57 
H-negative risk:  873 856 965 956 390 369 128 99 132 121 57 54 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
86 new agents 
52 
disease_progression 
H-positive risk:  856 887 99 960 364 129 958 379 121 55 132 60 
H-negative risk:  887 856 958 960 379 364 129 99 132 121 60 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
53 
disease_progression 
H-positive risk:  858 888 100 963 363 129 948 383 119 57 133 59 
H-negative risk:  888 858 948 963 383 363 129 100 133 119 59 57 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 74 22 

clinical_engagement 
diagnosis 
demography 
53 new agents 
54 
disease_progression 
H-positive risk:  865 896 100 953 370 127 941 381 117 58 132 60 
H-negative risk:  896 865 941 953 381 370 127 100 132 117 60 58 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
55 
disease_progression 
H-positive risk:  869 892 102 966 367 127 934 375 121 54 133 60 
H-negative risk:  892 869 934 966 375 367 127 102 133 121 60 54 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
56 
disease_progression 
H-positive risk:  866 898 103 962 370 128 928 379 123 51 131 61 
H-negative risk:  898 866 928 962 379 370 128 103 131 123 61 51 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
63 new agents 
57 
disease_progression 
H-positive risk:  866 897 100 963 367 128 930 379 123 53 133 61 
H-negative risk:  897 866 930 963 379 367 128 100 133 123 61 53 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
58 
disease_progression 
H-positive risk:  872 896 103 959 362 131 928 381 121 56 132 59 
H-negative risk:  896 872 928 959 381 362 131 103 132 121 59 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
59 
disease_progression 
H-positive risk:  875 894 104 963 353 131 925 383 127 57 131 57 
H-negative risk:  894 875 925 963 383 353 131 104 131 127 57 57 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
60 
disease_progression 
H-positive risk:  884 894 105 964 355 129 919 381 126 58 130 55 
H-negative risk:  894 884 919 964 381 355 129 105 130 126 55 58 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
61 
disease_progression 
H-positive risk:  838 836 108 1027 348 128 959 377 133 57 134 55 
H-negative risk:  836 838 959 1027 377 348 128 108 134 133 55 57 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
118 new agents 
62 
disease_progression 
H-positive risk:  845 829 113 1001 370 127 945 389 135 62 121 63 
H-negative risk:  829 845 945 1001 389 370 127 113 121 135 63 62 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
59 new agents 
63 
disease_progression 
H-positive risk:  848 828 113 1000 372 128 942 391 136 61 117 64 
H-negative risk:  828 848 942 1000 391 372 128 113 117 136 64 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
64 
disease_progression 
H-positive risk:  846 825 110 1006 365 130 950 393 135 60 116 64 
H-negative risk:  825 846 950 1006 393 365 130 110 116 135 64 60 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
65 
disease_progression 
H-positive risk:  847 823 111 1013 363 128 950 391 136 59 116 63 
H-negative risk:  823 847 950 1013 391 363 128 111 116 136 63 59 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
66 
disease_progression 
H-positive risk:  845 828 113 1010 359 126 959 387 135 59 118 61 
H-negative risk:  828 845 959 1010 387 359 126 113 118 135 61 59 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
67 
disease_progression 
H-positive risk:  838 832 112 1016 357 123 961 383 136 60 121 61 
H-negative risk:  832 838 961 1016 383 357 123 112 121 136 61 60 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
59 new agents 
68 
disease_progression 
H-positive risk:  837 830 112 1017 361 124 960 384 134 60 120 61 
H-negative risk:  830 837 960 1017 384 361 124 112 120 134 61 60 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
69 
disease_progression 
H-positive risk:  838 831 109 1016 365 127 965 378 130 60 119 62 
H-negative risk:  831 838 965 1016 378 365 127 109 119 130 62 60 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
70 
disease_progression 
H-positive risk:  842 832 108 1027 362 122 961 376 129 58 120 63 
H-negative risk:  832 842 961 1027 376 362 122 108 120 129 63 58 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
71 
disease_progression 
H-positive risk:  844 844 110 1026 361 123 962 369 130 53 119 59 
H-negative risk:  844 844 962 1026 369 361 123 110 119 130 59 53 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
49 new agents 
72 
disease_progression 
H-positive risk:  848 844 109 1033 359 122 957 369 131 53 117 58 
H-negative risk:  844 848 957 1033 369 359 122 109 117 131 58 53 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
63 new agents 
73 
disease_progression 
H-positive risk:  800 793 105 1085 353 114 1009 371 143 50 122 55 
H-negative risk:  793 800 1009 1085 371 353 114 105 122 143 55 50 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 87 28 

clinical_engagement 
diagnosis 
demography 
123 new agents 
74 
disease_progression 
H-positive risk:  806 799 107 1067 361 117 1007 367 138 56 120 55 
H-negative risk:  799 806 1007 1067 367 361 117 107 120 138 55 56 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 92 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
75 
disease_progression 
H-positive risk:  805 804 106 1054 365 118 1005 373 138 55 120 57 
H-negative risk:  804 805 1005 1054 373 365 118 106 120 138 57 55 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
76 
disease_progression 
H-positive risk:  807 800 106 1057 365 120 1003 371 138 57 122 54 
H-negative risk:  800 807 1003 1057 371 365 120 106 122 138 54 57 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 93 26 

clinical_engagement 
diagnosis 
demography 
85 new agents 
77 
disease_progression 
H-positive risk:  822 806 111 1043 367 120 991 370 140 54 120 56 
H-negative risk:  806 822 991 1043 370 367 120 111 120 140 56 54 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 91 28 

clinical_engagement 
diagnosis 
demography 
62 new agents 
78 
disease_progression 
H-positive risk:  824 803 113 1046 365 123 990 368 141 54 120 53 
H-negative risk:  803 824 990 1046 368 365 123 113 120 141 53 54 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 89 28 

clinical_engagement 
diagnosis 
demography 
69 new agents 
79 
disease_progression 
H-positive risk:  830 811 110 1046 357 122 986 367 143 51 123 54 
H-negative risk:  811 830 986 1046 367 357 122 110 123 143 54 51 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 92 27 

clinical_engagement 
diagnosis 
demography 
60 new agents 
80 
disease_progression 
H-positive risk:  832 813 109 1047 359 121 983 364 141 55 122 54 
H-negative risk:  813 832 983 1047 364 359 121 109 122 141 54 55 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 93 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
81 
disease_progression 
H-positive risk:  832 815 111 1046 354 118 984 370 139 55 121 55 
H-negative risk:  815 832 984 1046 370 354 118 111 121 139 55 55 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
82 
disease_progression 
H-positive risk:  832 819 111 1043 359 117 983 372 141 52 116 55 
H-negative risk:  819 832 983 1043 372 359 117 111 116 141 55 52 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 91 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
83 
disease_progression 
H-positive risk:  835 816 113 1046 359 118 983 371 137 51 116 55 
H-negative risk:  816 835 983 1046 371 359 118 113 116 137 55 51 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 93 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
84 
disease_progression 
H-positive risk:  836 812 114 1043 351 120 989 372 137 51 119 56 
H-negative risk:  812 836 989 1043 372 351 120 114 119 137 56 51 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 93 25 

clinical_engagement 
diagnosis 
demography 
63 new agents 
85 
disease_progression 
H-positive risk:  785 767 105 1090 349 109 1040 365 149 51 133 57 
H-negative risk:  767 785 1040 1090 365 349 109 105 133 149 57 51 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 91 26 

clinical_engagement 
diagnosis 
demography 
93 new agents 
86 
disease_progression 
H-positive risk:  780 771 105 1083 361 107 1028 374 150 50 132 59 
H-negative risk:  771 780 1028 1083 374 361 107 105 132 150 59 50 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 90 27 

clinical_engagement 
diagnosis 
demography 
79 new agents 
87 
disease_progression 
H-positive risk:  772 773 104 1087 360 103 1031 380 151 47 135 57 
H-negative risk:  773 772 1031 1087 380 360 103 104 135 151 57 47 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 93 28 

clinical_engagement 
diagnosis 
demography 
62 new agents 
88 
disease_progression 
H-positive risk:  781 769 103 1083 356 105 1037 374 153 48 135 56 
H-negative risk:  769 781 1037 1083 374 356 105 103 135 153 56 48 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 92 29 

clinical_engagement 
diagnosis 
demography 
76 new agents 
89 
disease_progression 
H-positive risk:  783 762 101 1083 359 105 1041 369 157 47 138 55 
H-negative risk:  762 783 1041 1083 369 359 105 101 138 157 55 47 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 92 29 

clinical_engagement 
diagnosis 
demography 
75 new agents 
90 
disease_progression 
H-positive risk:  783 756 102 1080 361 103 1048 368 157 47 140 55 
H-negative risk:  756 783 1048 1080 368 361 103 102 140 157 55 47 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 94 28 

clinical_engagement 
diagnosis 
demography 
61 new agents 
91 
disease_progression 
H-positive risk:  782 755 102 1090 357 101 1054 363 157 48 138 53 
H-negative risk:  755 782 1054 1090 363 357 101 102 138 157 53 48 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 92 27 

clinical_engagement 
diagnosis 
demography 
53 new agents 
92 
disease_progression 
H-positive risk:  784 754 102 1083 360 101 1053 372 158 46 136 51 
H-negative risk:  754 784 1053 1083 372 360 101 102 136 158 51 46 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 91 27 

clinical_engagement 
diagnosis 
demography 
61 new agents 
93 
disease_progression 
H-positive risk:  786 756 100 1079 361 103 1051 376 158 46 134 50 
H-negative risk:  756 786 1051 1079 376 361 103 100 134 158 50 46 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 92 27 

clinical_engagement 
diagnosis 
demography 
62 new agents 
94 
disease_progression 
H-positive risk:  780 757 102 1078 367 103 1052 378 159 41 134 49 
H-negative risk:  757 780 1052 1078 378 367 103 102 134 159 49 41 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 94 28 

clinical_engagement 
diagnosis 
demography 
74 new agents 
95 
disease_progression 
H-positive risk:  778 757 103 1073 371 104 1059 371 156 44 135 49 
H-negative risk:  757 778 1059 1073 371 371 104 103 135 156 49 44 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 94 28 

clinical_engagement 
diagnosis 
demography 
71 new agents 
96 
disease_progression 
H-positive risk:  772 757 106 1071 376 106 1061 367 154 43 138 49 
H-negative risk:  757 772 1061 1071 367 376 106 106 138 154 49 43 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 93 30 

clinical_engagement 
diagnosis 
demography 
80 new agents 
97 
disease_progression 
H-positive risk:  743 707 99 1116 377 97 1100 367 159 43 146 46 
H-negative risk:  707 743 1100 1116 367 377 97 99 146 159 46 43 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 89 29 

clinical_engagement 
diagnosis 
demography 
106 new agents 
98 
disease_progression 
H-positive risk:  738 702 97 1101 402 97 1085 383 153 45 150 47 
H-negative risk:  702 738 1085 1101 383 402 97 97 150 153 47 45 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 85 29 

clinical_engagement 
diagnosis 
demography 
80 new agents 
99 
disease_progression 
H-positive risk:  745 700 96 1104 403 97 1086 379 154 43 147 46 
H-negative risk:  700 745 1086 1104 379 403 97 96 147 154 46 43 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 84 29 

clinical_engagement 
diagnosis 
demography 
66 new agents 
100 
disease_progression 
H-positive risk:  748 700 94 1108 401 99 1090 376 150 44 144 46 
H-negative risk:  700 748 1090 1108 376 401 99 94 144 150 46 44 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 83 29 

clinical_engagement 
diagnosis 
demography 
67 new agents 
101 
disease_progression 
H-positive risk:  742 707 96 1107 400 99 1088 379 150 43 144 45 
H-negative risk:  707 742 1088 1107 379 400 99 96 144 150 45 43 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 85 30 

clinical_engagement 
diagnosis 
demography 
80 new agents 
102 
disease_progression 
H-positive risk:  745 708 100 1103 398 101 1087 377 148 44 145 44 
H-negative risk:  708 745 1087 1103 377 398 101 100 145 148 44 44 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 86 30 

clinical_engagement 
diagnosis 
demography 
75 new agents 
103 
disease_progression 
H-positive risk:  747 700 103 1109 393 103 1089 378 147 47 145 39 
H-negative risk:  700 747 1089 1109 378 393 103 103 145 147 39 47 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 84 30 

clinical_engagement 
diagnosis 
demography 
66 new agents 
104 
disease_progression 
H-positive risk:  752 704 100 1101 397 105 1082 383 147 45 146 38 
H-negative risk:  704 752 1082 1101 383 397 105 100 146 147 38 45 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 84 32 

clinical_engagement 
diagnosis 
demography 
70 new agents 
105 
disease_progression 
H-positive risk:  745 711 102 1090 391 108 1094 384 145 47 142 41 
H-negative risk:  711 745 1094 1090 384 391 108 102 142 145 41 47 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 87 32 

clinical_engagement 
diagnosis 
demography 
61 new agents 
106 
disease_progression 
H-positive risk:  732 712 102 1090 398 106 1105 377 148 47 144 39 
H-negative risk:  712 732 1105 1090 377 398 106 102 144 148 39 47 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 86 32 

clinical_engagement 
diagnosis 
demography 
65 new agents 
107 
disease_progression 
H-positive risk:  737 708 101 1092 401 107 1098 374 145 50 146 41 
H-negative risk:  708 737 1098 1092 374 401 107 101 146 145 41 50 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 84 31 

clinical_engagement 
diagnosis 
demography 
76 new agents 
108 
disease_progression 
H-positive risk:  750 707 99 1093 401 106 1099 364 145 48 146 42 
H-negative risk:  707 750 1099 1093 364 401 106 99 146 145 42 48 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 82 33 

clinical_engagement 
diagnosis 
demography 
84 new agents 
109 
disease_progression 
H-positive risk:  706 664 92 1136 408 102 1151 352 147 48 152 42 
H-negative risk:  664 706 1151 1136 352 408 102 92 152 147 42 48 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 84 33 

clinical_engagement 
diagnosis 
demography 
95 new agents 
110 
disease_progression 
H-positive risk:  701 660 94 1117 427 104 1141 368 144 49 150 45 
H-negative risk:  660 701 1141 1117 368 427 104 94 150 144 45 49 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 80 33 

clinical_engagement 
diagnosis 
demography 
78 new agents 
111 
disease_progression 
H-positive risk:  691 670 96 1103 434 105 1137 372 144 50 152 46 
H-negative risk:  670 691 1137 1103 372 434 105 96 152 144 46 50 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 77 33 

clinical_engagement 
diagnosis 
demography 
69 new agents 
112 
disease_progression 
H-positive risk:  693 673 97 1105 431 105 1129 377 145 50 149 46 
H-negative risk:  673 693 1129 1105 377 431 105 97 149 145 46 50 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 79 33 

clinical_engagement 
diagnosis 
demography 
77 new agents 
113 
disease_progression 
H-positive risk:  698 672 95 1105 429 105 1138 368 144 50 148 48 
H-negative risk:  672 698 1138 1105 368 429 105 95 148 144 48 50 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 78 33 

clinical_engagement 
diagnosis 
demography 
63 new agents 
114 
disease_progression 
H-positive risk:  703 684 96 1097 427 102 1141 362 144 50 146 48 
H-negative risk:  684 703 1141 1097 362 427 102 96 146 144 48 50 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 83 33 

clinical_engagement 
diagnosis 
demography 
71 new agents 
115 
disease_progression 
H-positive risk:  699 686 95 1098 425 104 1143 365 141 50 147 47 
H-negative risk:  686 699 1143 1098 365 425 104 95 147 141 47 50 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 84 33 

clinical_engagement 
diagnosis 
demography 
59 new agents 
116 
disease_progression 
H-positive risk:  698 689 94 1100 423 107 1140 365 140 51 146 47 
H-negative risk:  689 698 1140 1100 365 423 107 94 146 140 47 51 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 86 33 

clinical_engagement 
diagnosis 
demography 
85 new agents 
117 
disease_progression 
H-positive risk:  712 698 95 1092 418 106 1142 357 137 50 144 49 
H-negative risk:  698 712 1142 1092 357 418 106 95 144 137 49 50 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 86 33 

clinical_engagement 
diagnosis 
demography 
77 new agents 
118 
disease_progression 
H-positive risk:  715 698 95 1094 421 104 1137 355 140 48 142 51 
H-negative risk:  698 715 1137 1094 355 421 104 95 142 140 51 48 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 87 31 

clinical_engagement 
diagnosis 
demography 
63 new agents 
119 
disease_progression 
H-positive risk:  710 694 94 1095 419 104 1135 362 141 47 147 52 
H-negative risk:  694 710 1135 1095 362 419 104 94 147 141 52 47 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 86 32 

clinical_engagement 
diagnosis 
demography 
80 new agents 
120 
disease_progression 
H-positive risk:  706 702 94 1082 418 104 1147 356 143 48 147 53 
H-negative risk:  702 706 1147 1082 356 418 104 94 147 143 53 48 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 85 34 

clinical_engagement 
diagnosis 
demography 
84 new agents 
121 
disease_progression 
H-positive risk:  665 671 89 1128 408 99 1186 357 147 47 151 52 
H-negative risk:  671 665 1186 1128 357 408 99 89 151 147 52 47 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 84 33 

clinical_engagement 
diagnosis 
demography 
104 new agents 
122 
disease_progression 
H-positive risk:  653 675 89 1123 426 99 1177 363 147 47 151 50 
H-negative risk:  675 653 1177 1123 363 426 99 89 151 147 50 47 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 82 33 

clinical_engagement 
diagnosis 
demography 
66 new agents 
123 
disease_progression 
H-positive risk:  658 674 89 1116 428 96 1171 369 150 48 149 52 
H-negative risk:  674 658 1171 1116 369 428 96 89 149 150 52 48 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 81 33 

clinical_engagement 
diagnosis 
demography 
72 new agents 
124 
disease_progression 
H-positive risk:  668 669 87 1118 418 95 1177 374 149 50 146 49 
H-negative risk:  669 668 1177 1118 374 418 95 87 146 149 49 50 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 83 33 

clinical_engagement 
diagnosis 
demography 
72 new agents 
125 
disease_progression 
H-positive risk:  668 667 90 1127 415 95 1176 368 152 47 146 49 
H-negative risk:  667 668 1176 1127 368 415 95 90 146 152 49 47 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 82 34 

clinical_engagement 
diagnosis 
demography 
74 new agents 
126 
disease_progression 
H-positive risk:  662 666 87 1138 412 94 1176 370 154 43 147 51 
H-negative risk:  666 662 1176 1138 370 412 94 87 147 154 51 43 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 81 35 

clinical_engagement 
diagnosis 
demography 
71 new agents 
127 
disease_progression 
H-positive risk:  664 671 87 1132 413 94 1178 369 153 40 149 50 
H-negative risk:  671 664 1178 1132 369 413 94 87 149 153 50 40 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 82 34 

clinical_engagement 
diagnosis 
demography 
87 new agents 
128 
disease_progression 
H-positive risk:  666 672 87 1136 412 93 1174 367 154 41 148 50 
H-negative risk:  672 666 1174 1136 367 412 93 87 148 154 50 41 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 83 33 

clinical_engagement 
diagnosis 
demography 
81 new agents 
129 
disease_progression 
H-positive risk:  663 671 87 1131 411 94 1187 359 157 40 150 50 
H-negative risk:  671 663 1187 1131 359 411 94 87 150 157 50 40 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 79 32 

clinical_engagement 
diagnosis 
demography 
74 new agents 
130 
disease_progression 
H-positive risk:  664 675 88 1141 405 91 1185 352 162 41 149 47 
H-negative risk:  675 664 1185 1141 352 405 91 88 149 162 47 41 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 79 33 

clinical_engagement 
diagnosis 
demography 
79 new agents 
131 
disease_progression 
H-positive risk:  663 681 85 1144 401 87 1187 353 163 41 151 44 
H-negative risk:  681 663 1187 1144 353 401 87 85 151 163 44 41 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 82 33 

clinical_engagement 
diagnosis 
demography 
62 new agents 
132 
disease_progression 
H-positive risk:  659 683 82 1149 392 86 1191 359 162 42 150 45 
H-negative risk:  683 659 1191 1149 359 392 86 82 150 162 45 42 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 85 33 

clinical_engagement 
diagnosis 
demography 
69 new agents 
133 
disease_progression 
H-positive risk:  651 683 85 1152 384 87 1198 357 162 43 153 45 
H-negative risk:  683 651 1198 1152 357 384 87 85 153 162 45 43 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 84 30 

clinical_engagement 
diagnosis 
demography 
89 new agents 
134 
disease_progression 
H-positive risk:  656 685 83 1143 379 88 1183 379 164 41 153 46 
H-negative risk:  685 656 1183 1143 379 379 88 83 153 164 46 41 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 82 31 

clinical_engagement 
diagnosis 
demography 
74 new agents 
135 
disease_progression 
H-positive risk:  657 682 84 1150 380 88 1176 387 162 39 149 46 
H-negative risk:  682 657 1176 1150 387 380 88 84 149 162 46 39 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 83 32 

clinical_engagement 
diagnosis 
demography 
72 new agents 
136 
disease_progression 
H-positive risk:  652 676 83 1143 384 89 1184 391 164 39 146 49 
H-negative risk:  676 652 1184 1143 391 384 89 83 146 164 49 39 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 84 31 

clinical_engagement 
diagnosis 
demography 
66 new agents 
137 
disease_progression 
H-positive risk:  647 673 83 1144 382 87 1190 396 165 41 145 47 
H-negative risk:  673 647 1190 1144 396 382 87 83 145 165 47 41 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 85 31 

clinical_engagement 
diagnosis 
demography 
66 new agents 
138 
disease_progression 
H-positive risk:  647 669 80 1142 386 89 1188 400 163 42 148 46 
H-negative risk:  669 647 1188 1142 400 386 89 80 148 163 46 42 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 84 31 

clinical_engagement 
diagnosis 
demography 
69 new agents 
139 
disease_progression 
H-positive risk:  640 670 82 1147 383 91 1185 402 165 41 146 48 
H-negative risk:  670 640 1185 1147 402 383 91 82 146 165 48 41 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 86 31 

clinical_engagement 
diagnosis 
demography 
81 new agents 
140 
disease_progression 
H-positive risk:  638 673 82 1150 383 91 1182 405 163 40 145 48 
H-negative risk:  673 638 1182 1150 405 383 91 82 145 163 48 40 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 89 31 

clinical_engagement 
diagnosis 
demography 
72 new agents 
141 
disease_progression 
H-positive risk:  639 679 84 1156 374 90 1183 406 159 40 141 49 
H-negative risk:  679 639 1183 1156 406 374 90 84 141 159 49 40 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 92 32 

clinical_engagement 
diagnosis 
demography 
81 new agents 
142 
disease_progression 
H-positive risk:  644 675 84 1158 366 90 1183 408 163 40 141 48 
H-negative risk:  675 644 1183 1158 408 366 90 84 141 163 48 40 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 90 30 

clinical_engagement 
diagnosis 
demography 
83 new agents 
143 
disease_progression 
H-positive risk:  652 671 87 1154 361 89 1185 409 162 40 143 47 
H-negative risk:  671 652 1185 1154 409 361 89 87 143 162 47 40 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 88 30 

clinical_engagement 
diagnosis 
demography 
68 new agents 
144 
disease_progression 
H-positive risk:  650 671 88 1154 356 87 1195 405 164 41 143 46 
H-negative risk:  671 650 1195 1154 405 356 87 88 143 164 46 41 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 87 30 

clinical_engagement 
diagnosis 
demography 
75 new agents 
145 
disease_progression 
H-positive risk:  656 663 89 1159 358 86 1196 401 164 40 142 46 
H-negative risk:  663 656 1196 1159 401 358 86 89 142 164 46 40 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 88 27 

clinical_engagement 
diagnosis 
demography 
85 new agents 
146 
disease_progression 
H-positive risk:  652 666 87 1150 376 84 1182 407 166 40 143 47 
H-negative risk:  666 652 1182 1150 407 376 84 87 143 166 47 40 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
147 
disease_progression 
H-positive risk:  662 663 88 1155 376 85 1176 403 165 42 140 45 
H-negative risk:  663 662 1176 1155 403 376 85 88 140 165 45 42 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
110 new agents 
148 
disease_progression 
H-positive risk:  667 664 90 1159 376 85 1170 396 168 40 136 49 
H-negative risk:  664 667 1170 1159 396 376 85 90 136 168 49 40 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
149 
disease_progression 
H-positive risk:  661 657 89 1166 380 87 1178 393 167 41 134 47 
H-negative risk:  657 661 1178 1166 393 380 87 89 134 167 47 41 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
87 new agents 
150 
disease_progression 
H-positive risk:  667 659 88 1166 376 87 1173 391 166 41 141 45 
H-negative risk:  659 667 1173 1166 391 376 87 88 141 166 45 41 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
151 
disease_progression 
H-positive risk:  663 669 88 1165 368 87 1171 397 163 40 144 45 
H-negative risk:  669 663 1171 1165 397 368 87 88 144 163 45 40 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
152 
disease_progression 
H-positive risk:  662 665 89 1169 370 86 1168 394 163 43 143 48 
H-negative risk:  665 662 1168 1169 394 370 86 89 143 163 48 43 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 88 25 

clinical_engagement 
diagnosis 
demography 
93 new agents 
153 
disease_progression 
H-positive risk:  648 666 89 1168 374 85 1172 405 160 40 144 49 
H-negative risk:  666 648 1172 1168 405 374 85 89 144 160 49 40 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 91 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
154 
disease_progression 
H-positive risk:  646 664 90 1159 386 87 1181 397 160 40 145 45 
H-negative risk:  664 646 1181 1159 397 386 87 90 145 160 45 40 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 91 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
155 
disease_progression 
H-positive risk:  649 669 87 1151 394 89 1174 395 158 41 149 44 
H-negative risk:  669 649 1174 1151 395 394 89 87 149 158 44 41 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 94 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
156 
disease_progression 
H-positive risk:  655 667 84 1162 394 90 1162 395 156 44 146 45 
H-negative risk:  667 655 1162 1162 395 394 90 84 146 156 45 44 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 97 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
157 
disease_progression 
H-positive risk:  657 663 81 1158 396 91 1173 388 154 45 148 46 
H-negative risk:  663 657 1173 1158 388 396 91 81 148 154 46 45 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 96 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
158 
disease_progression 
H-positive risk:  654 662 82 1157 402 89 1160 404 149 47 150 44 
H-negative risk:  662 654 1160 1157 404 402 89 82 150 149 44 47 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 97 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
159 
disease_progression 
H-positive risk:  657 658 81 1143 409 90 1162 411 147 46 153 43 
H-negative risk:  658 657 1162 1143 411 409 90 81 153 147 43 46 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 95 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
160 
disease_progression 
H-positive risk:  659 660 79 1141 415 89 1157 409 148 46 154 43 
H-negative risk:  660 659 1157 1141 409 415 89 79 154 148 43 46 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 95 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
161 
disease_progression 
H-positive risk:  666 658 80 1142 416 91 1149 408 150 45 153 42 
H-negative risk:  658 666 1149 1142 408 416 91 80 153 150 42 45 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 93 22 

clinical_engagement 
diagnosis 
demography 
82 new agents 
162 
disease_progression 
H-positive risk:  661 660 77 1140 425 90 1147 406 151 45 156 42 
H-negative risk:  660 661 1147 1140 406 425 90 77 156 151 42 45 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 93 20 

clinical_engagement 
diagnosis 
demography 
85 new agents 
163 
disease_progression 
H-positive risk:  659 662 78 1139 429 89 1140 403 153 46 157 45 
H-negative risk:  662 659 1140 1139 403 429 89 78 157 153 45 46 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 94 21 

clinical_engagement 
diagnosis 
demography 
68 new agents 
164 
disease_progression 
H-positive risk:  657 659 84 1136 429 87 1139 404 153 48 156 48 
H-negative risk:  659 657 1139 1136 404 429 87 84 156 153 48 48 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 95 24 

clinical_engagement 
diagnosis 
demography 
60 new agents 
165 
disease_progression 
H-positive risk:  659 650 84 1139 430 87 1145 407 149 49 154 47 
H-negative risk:  650 659 1145 1139 407 430 87 84 154 149 47 49 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 95 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
166 
disease_progression 
H-positive risk:  657 653 84 1134 436 86 1138 406 149 50 159 48 
H-negative risk:  653 657 1138 1134 406 436 86 84 159 149 48 50 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 94 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
167 
disease_progression 
H-positive risk:  661 653 86 1134 422 88 1138 407 148 50 163 50 
H-negative risk:  653 661 1138 1134 407 422 88 86 163 148 50 50 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 92 24 

clinical_engagement 
diagnosis 
demography 
64 new agents 
168 
disease_progression 
H-positive risk:  665 648 86 1132 423 89 1139 409 145 54 156 54 
H-negative risk:  648 665 1139 1132 409 423 89 86 156 145 54 54 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 93 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
169 
disease_progression 
H-positive risk:  671 652 86 1127 419 90 1145 402 144 53 156 55 
H-negative risk:  652 671 1145 1127 402 419 90 86 156 144 55 53 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
101 new agents 
170 
disease_progression 
H-positive risk:  683 652 86 1118 420 90 1126 418 145 53 152 57 
H-negative risk:  652 683 1126 1118 418 420 90 86 152 145 57 53 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 90 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
171 
disease_progression 
H-positive risk:  686 646 86 1115 425 89 1127 417 146 51 152 60 
H-negative risk:  646 686 1127 1115 417 425 89 86 152 146 60 51 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
86 new agents 
172 
disease_progression 
H-positive risk:  684 642 86 1119 422 89 1137 410 145 53 152 61 
H-negative risk:  642 684 1137 1119 410 422 89 86 152 145 61 53 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
80 new agents 
173 
disease_progression 
H-positive risk:  689 643 86 1119 421 89 1131 410 146 50 155 61 
H-negative risk:  643 689 1131 1119 410 421 89 86 155 146 61 50 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 82 28 

clinical_engagement 
diagnosis 
demography 
84 new agents 
174 
disease_progression 
H-positive risk:  701 644 83 1113 420 90 1126 410 146 51 157 59 
H-negative risk:  644 701 1126 1113 410 420 90 83 157 146 59 51 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 79 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
175 
disease_progression 
H-positive risk:  705 639 85 1112 428 89 1119 411 141 52 158 61 
H-negative risk:  639 705 1119 1112 411 428 89 85 158 141 61 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
89 new agents 
176 
disease_progression 
H-positive risk:  708 638 85 1106 429 89 1116 414 142 56 157 60 
H-negative risk:  638 708 1116 1106 414 429 89 85 157 142 60 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
82 new agents 
177 
disease_progression 
H-positive risk:  712 645 83 1095 430 89 1113 409 146 55 161 62 
H-negative risk:  645 712 1113 1095 409 430 89 83 161 146 62 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 77 26 

clinical_engagement 
diagnosis 
demography 
85 new agents 
178 
disease_progression 
H-positive risk:  707 645 82 1098 428 89 1124 404 145 57 160 61 
H-negative risk:  645 707 1124 1098 404 428 89 82 160 145 61 57 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
179 
disease_progression 
H-positive risk:  706 646 82 1105 431 89 1123 397 146 56 160 59 
H-negative risk:  646 706 1123 1105 397 431 89 82 160 146 59 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 77 28 

clinical_engagement 
diagnosis 
demography 
81 new agents 
180 
disease_progression 
H-positive risk:  702 647 84 1114 436 91 1111 400 146 53 158 58 
H-negative risk:  647 702 1111 1114 400 436 91 84 158 146 58 53 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 73 30 

clinical_engagement 
diagnosis 
demography 
83 new agents 
181 
disease_progression 
H-positive risk:  694 648 84 1102 446 90 1123 395 148 53 159 58 
H-negative risk:  648 694 1123 1102 395 446 90 84 159 148 58 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
85 new agents 
182 
disease_progression 
H-positive risk:  693 651 85 1089 457 88 1123 393 149 56 156 60 
H-negative risk:  651 693 1123 1089 393 457 88 85 156 149 60 56 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 71 31 

clinical_engagement 
diagnosis 
demography 
79 new agents 
183 
disease_progression 
H-positive risk:  691 651 84 1094 456 88 1132 381 149 55 161 58 
H-negative risk:  651 691 1132 1094 381 456 88 84 161 149 58 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 73 31 

clinical_engagement 
diagnosis 
demography 
83 new agents 
184 
disease_progression 
H-positive risk:  684 646 84 1096 447 88 1137 390 151 56 163 58 
H-negative risk:  646 684 1137 1096 390 447 88 84 163 151 58 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 73 30 

clinical_engagement 
diagnosis 
demography 
74 new agents 
185 
disease_progression 
H-positive risk:  685 649 81 1089 447 88 1140 390 153 53 165 60 
H-negative risk:  649 685 1140 1089 390 447 88 81 165 153 60 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 74 30 

clinical_engagement 
diagnosis 
demography 
79 new agents 
186 
disease_progression 
H-positive risk:  683 650 84 1087 455 86 1134 390 153 53 165 60 
H-negative risk:  650 683 1134 1087 390 455 86 84 165 153 60 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 75 29 

clinical_engagement 
diagnosis 
demography 
68 new agents 
187 
disease_progression 
H-positive risk:  683 646 81 1093 455 85 1128 392 154 54 166 63 
H-negative risk:  646 683 1128 1093 392 455 85 81 166 154 63 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 72 29 

clinical_engagement 
diagnosis 
demography 
73 new agents 
188 
disease_progression 
H-positive risk:  673 660 83 1099 451 86 1120 394 152 51 166 65 
H-negative risk:  660 673 1120 1099 394 451 86 83 166 152 65 51 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 68 27 

clinical_engagement 
diagnosis 
demography 
83 new agents 
189 
disease_progression 
H-positive risk:  669 658 83 1105 448 88 1121 399 148 53 166 62 
H-negative risk:  658 669 1121 1105 399 448 88 83 166 148 62 53 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 68 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
190 
disease_progression 
H-positive risk:  675 657 83 1108 446 88 1118 398 146 54 165 62 
H-negative risk:  657 675 1118 1108 398 446 88 83 165 146 62 54 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 67 29 

clinical_engagement 
diagnosis 
demography 
80 new agents 
191 
disease_progression 
H-positive risk:  671 668 87 1098 446 90 1109 406 140 57 166 62 
H-negative risk:  668 671 1109 1098 406 446 90 87 166 140 62 57 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 69 31 

clinical_engagement 
diagnosis 
demography 
86 new agents 
192 
disease_progression 
H-positive risk:  677 673 89 1074 445 92 1110 414 139 55 167 65 
H-negative risk:  673 677 1110 1074 414 445 92 89 167 139 65 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 72 30 

clinical_engagement 
diagnosis 
demography 
58 new agents 
193 
disease_progression 
H-positive risk:  673 672 89 1074 444 93 1112 420 138 57 165 63 
H-negative risk:  672 673 1112 1074 420 444 93 89 165 138 63 57 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 70 31 

clinical_engagement 
diagnosis 
demography 
100 new agents 
194 
disease_progression 
H-positive risk:  674 675 90 1063 445 93 1108 426 138 59 165 64 
H-negative risk:  675 674 1108 1063 426 445 93 90 165 138 64 59 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 70 28 

clinical_engagement 
diagnosis 
demography 
89 new agents 
195 
disease_progression 
H-positive risk:  684 671 90 1056 448 92 1100 426 141 58 166 68 
H-negative risk:  671 684 1100 1056 426 448 92 90 166 141 68 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 69 29 

clinical_engagement 
diagnosis 
demography 
71 new agents 
196 
disease_progression 
H-positive risk:  680 667 92 1059 451 95 1096 431 142 57 163 67 
H-negative risk:  667 680 1096 1059 431 451 95 92 163 142 67 57 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 70 28 

clinical_engagement 
diagnosis 
demography 
77 new agents 
197 
disease_progression 
H-positive risk:  685 669 92 1058 457 98 1084 428 142 58 162 67 
H-negative risk:  669 685 1084 1058 428 457 98 92 162 142 67 58 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 70 30 

clinical_engagement 
diagnosis 
demography 
82 new agents 
198 
disease_progression 
H-positive risk:  691 669 93 1056 446 100 1084 429 144 59 162 67 
H-negative risk:  669 691 1084 1056 429 446 100 93 162 144 67 59 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 73 31 

clinical_engagement 
diagnosis 
demography 
86 new agents 
199 
disease_progression 
H-positive risk:  686 677 96 1072 440 101 1079 422 145 56 159 67 
H-negative risk:  677 686 1079 1072 422 440 101 96 159 145 67 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 72 34 

clinical_engagement 
diagnosis 
demography 
79 new agents 
200 
disease_progression 
H-positive risk:  693 684 98 1063 432 101 1080 419 146 57 159 68 
H-negative risk:  684 693 1080 1063 419 432 101 98 159 146 68 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 72 33 

clinical_engagement 
diagnosis 
demography 
80 new agents 
201 
disease_progression 
H-positive risk:  694 682 99 1081 426 101 1082 409 147 55 160 64 
H-negative risk:  682 694 1082 1081 409 426 101 99 160 147 64 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 74 31 

clinical_engagement 
diagnosis 
demography 
90 new agents 
202 
disease_progression 
H-positive risk:  696 690 100 1069 424 102 1088 406 144 57 161 63 
H-negative risk:  690 696 1088 1069 406 424 102 100 161 144 63 57 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 77 31 

clinical_engagement 
diagnosis 
demography 
74 new agents 
203 
disease_progression 
H-positive risk:  695 697 97 1062 429 105 1080 407 145 59 162 62 
H-negative risk:  697 695 1080 1062 407 429 105 97 162 145 62 59 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 77 31 

clinical_engagement 
diagnosis 
demography 
77 new agents 
204 
disease_progression 
H-positive risk:  690 696 96 1056 438 104 1081 410 145 59 163 62 
H-negative risk:  696 690 1081 1056 410 438 104 96 163 145 62 59 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 77 28 

clinical_engagement 
diagnosis 
demography 
84 new agents 
205 
disease_progression 
H-positive risk:  686 703 100 1061 440 103 1079 404 140 58 163 63 
H-negative risk:  703 686 1079 1061 404 440 103 100 163 140 63 58 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 77 29 

clinical_engagement 
diagnosis 
demography 
80 new agents 
206 
disease_progression 
H-positive risk:  684 709 104 1054 440 106 1077 402 136 61 164 63 
H-negative risk:  709 684 1077 1054 402 440 106 104 164 136 63 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 79 28 

clinical_engagement 
diagnosis 
demography 
61 new agents 
207 
disease_progression 
H-positive risk:  679 714 105 1051 445 105 1074 405 137 62 160 63 
H-negative risk:  714 679 1074 1051 405 445 105 105 160 137 63 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 78 27 

clinical_engagement 
diagnosis 
demography 
67 new agents 
208 
disease_progression 
H-positive risk:  676 719 105 1047 444 104 1081 405 136 63 158 62 
H-negative risk:  719 676 1081 1047 405 444 104 105 158 136 62 63 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 78 27 

clinical_engagement 
diagnosis 
demography 
70 new agents 
209 
disease_progression 
H-positive risk:  671 731 103 1045 439 104 1081 408 135 64 158 61 
H-negative risk:  731 671 1081 1045 408 439 104 103 158 135 61 64 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
210 
disease_progression 
H-positive risk:  659 732 101 1041 444 102 1080 421 135 67 157 61 
H-negative risk:  732 659 1080 1041 421 444 102 101 157 135 61 67 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
211 
disease_progression 
H-positive risk:  664 725 102 1045 442 101 1081 420 137 65 155 63 
H-negative risk:  725 664 1081 1045 420 442 101 102 155 137 63 65 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
90 new agents 
212 
disease_progression 
H-positive risk:  666 726 102 1043 438 103 1082 419 138 68 157 58 
H-negative risk:  726 666 1082 1043 419 438 103 102 157 138 58 68 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
213 
disease_progression 
H-positive risk:  668 718 102 1054 434 99 1087 419 139 70 155 55 
H-negative risk:  718 668 1087 1054 419 434 99 102 155 139 55 70 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 82 28 

clinical_engagement 
diagnosis 
demography 
69 new agents 
214 
disease_progression 
H-positive risk:  669 720 102 1052 440 97 1077 421 139 71 159 53 
H-negative risk:  720 669 1077 1052 421 440 97 102 159 139 53 71 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 81 28 

clinical_engagement 
diagnosis 
demography 
87 new agents 
215 
disease_progression 
H-positive risk:  659 723 99 1057 448 94 1070 426 144 67 158 55 
H-negative risk:  723 659 1070 1057 426 448 94 99 158 144 55 67 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 82 27 

clinical_engagement 
diagnosis 
demography 
80 new agents 
216 
disease_progression 
H-positive risk:  657 719 100 1056 457 96 1075 419 147 64 153 57 
H-negative risk:  719 657 1075 1056 419 457 96 100 153 147 57 64 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 79 30 

clinical_engagement 
diagnosis 
demography 
77 new agents 
217 
disease_progression 
H-positive risk:  663 718 102 1039 468 96 1066 429 145 64 153 57 
H-negative risk:  718 663 1066 1039 429 468 96 102 153 145 57 64 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 79 30 

clinical_engagement 
diagnosis 
demography 
70 new agents 
218 
disease_progression 
H-positive risk:  660 710 104 1050 466 91 1071 419 150 66 152 61 
H-negative risk:  710 660 1071 1050 419 466 91 104 152 150 61 66 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 79 30 

clinical_engagement 
diagnosis 
demography 
79 new agents 
219 
disease_progression 
H-positive risk:  656 708 104 1050 474 95 1068 421 145 67 150 62 
H-negative risk:  708 656 1068 1050 421 474 95 104 150 145 62 67 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 80 30 

clinical_engagement 
diagnosis 
demography 
84 new agents 
220 
disease_progression 
H-positive risk:  659 711 104 1057 462 98 1069 414 144 69 150 63 
H-negative risk:  711 659 1069 1057 414 462 98 104 150 144 63 69 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 80 30 

clinical_engagement 
diagnosis 
demography 
75 new agents 
221 
disease_progression 
H-positive risk:  658 712 105 1059 460 100 1065 415 144 70 151 61 
H-negative risk:  712 658 1065 1059 415 460 100 105 151 144 61 70 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 79 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
222 
disease_progression 
H-positive risk:  663 704 106 1060 461 100 1068 416 142 70 148 62 
H-negative risk:  704 663 1068 1060 416 461 100 106 148 142 62 70 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
98 new agents 
223 
disease_progression 
H-positive risk:  680 706 107 1061 457 102 1065 407 143 68 141 63 
H-negative risk:  706 680 1065 1061 407 457 102 107 141 143 63 68 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
54 new agents 
224 
disease_progression 
H-positive risk:  674 706 105 1058 456 99 1070 412 143 72 144 61 
H-negative risk:  706 674 1070 1058 412 456 99 105 144 143 61 72 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 79 27 

clinical_engagement 
diagnosis 
demography 
66 new agents 
225 
disease_progression 
H-positive risk:  678 708 106 1046 459 99 1075 414 140 71 141 63 
H-negative risk:  708 678 1075 1046 414 459 99 106 141 140 63 71 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 76 27 

clinical_engagement 
diagnosis 
demography 
79 new agents 
226 
disease_progression 
H-positive risk:  680 707 101 1048 449 102 1078 413 144 70 146 62 
H-negative risk:  707 680 1078 1048 413 449 102 101 146 144 62 70 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
71 new agents 
227 
disease_progression 
H-positive risk:  683 705 103 1057 438 101 1065 424 146 69 145 64 
H-negative risk:  705 683 1065 1057 424 438 101 103 145 146 64 69 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 79 27 

clinical_engagement 
diagnosis 
demography 
74 new agents 
228 
disease_progression 
H-positive risk:  682 705 106 1055 440 103 1064 426 147 65 142 65 
H-negative risk:  705 682 1064 1055 426 440 103 106 142 147 65 65 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 79 27 

clinical_engagement 
diagnosis 
demography 
78 new agents 
229 
disease_progression 
H-positive risk:  686 694 105 1049 446 103 1061 435 146 69 144 62 
H-negative risk:  694 686 1061 1049 435 446 103 105 144 146 62 69 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
88 new agents 
230 
disease_progression 
H-positive risk:  689 687 108 1062 443 104 1070 418 149 68 142 60 
H-negative risk:  687 689 1070 1062 418 443 104 108 142 149 60 68 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 81 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
231 
disease_progression 
H-positive risk:  689 695 110 1067 427 100 1066 428 149 68 138 63 
H-negative risk:  695 689 1066 1067 428 427 100 110 138 149 63 68 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
232 
disease_progression 
H-positive risk:  692 689 112 1070 423 98 1072 427 150 68 137 62 
H-negative risk:  689 692 1072 1070 427 423 98 112 137 150 62 68 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
91 new agents 
233 
disease_progression 
H-positive risk:  694 688 114 1080 423 98 1072 423 151 63 135 59 
H-negative risk:  688 694 1072 1080 423 423 98 114 135 151 59 63 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 83 28 

clinical_engagement 
diagnosis 
demography 
56 new agents 
234 
disease_progression 
H-positive risk:  690 688 113 1072 423 98 1076 429 150 62 137 62 
H-negative risk:  688 690 1076 1072 429 423 98 113 137 150 62 62 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 87 27 

clinical_engagement 
diagnosis 
demography 
85 new agents 
235 
disease_progression 
H-positive risk:  690 687 108 1078 424 97 1072 425 152 62 144 61 
H-negative risk:  687 690 1072 1078 425 424 97 108 144 152 61 62 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 87 27 

clinical_engagement 
diagnosis 
demography 
85 new agents 
236 
disease_progression 
H-positive risk:  686 686 112 1084 418 102 1079 419 150 66 141 57 
H-negative risk:  686 686 1079 1084 419 418 102 112 141 150 57 66 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 88 27 

clinical_engagement 
diagnosis 
demography 
79 new agents 
237 
disease_progression 
H-positive risk:  686 689 112 1073 423 102 1089 419 143 66 141 57 
H-negative risk:  689 686 1089 1073 419 423 102 112 141 143 57 66 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 90 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
238 
disease_progression 
H-positive risk:  695 686 111 1077 419 100 1086 418 147 65 139 57 
H-negative risk:  686 695 1086 1077 418 419 100 111 139 147 57 65 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 92 28 

clinical_engagement 
diagnosis 
demography 
87 new agents 
239 
disease_progression 
H-positive risk:  698 687 110 1080 420 99 1086 407 148 65 144 56 
H-negative risk:  687 698 1086 1080 407 420 99 110 144 148 56 65 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 88 27 

clinical_engagement 
diagnosis 
demography 
74 new agents 
240 
disease_progression 
H-positive risk:  699 699 111 1082 416 99 1079 403 147 66 145 54 
H-negative risk:  699 699 1079 1082 403 416 99 111 145 147 54 66 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 90 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
241 
disease_progression 
H-positive risk:  693 699 112 1074 427 100 1067 417 139 71 143 58 
H-negative risk:  699 693 1067 1074 417 427 100 112 143 139 58 71 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 89 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
242 
disease_progression 
H-positive risk:  695 697 107 1079 419 96 1068 417 145 71 145 61 
H-negative risk:  697 695 1068 1079 417 419 96 107 145 145 61 71 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 89 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
243 
disease_progression 
H-positive risk:  695 693 107 1082 420 97 1058 426 144 69 148 61 
H-negative risk:  693 695 1058 1082 426 420 97 107 148 144 61 69 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 90 25 

clinical_engagement 
diagnosis 
demography 
87 new agents 
244 
disease_progression 
H-positive risk:  697 691 110 1076 429 101 1056 426 143 66 147 58 
H-negative risk:  691 697 1056 1076 426 429 101 110 147 143 58 66 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 86 29 

clinical_engagement 
diagnosis 
demography 
61 new agents 
245 
disease_progression 
H-positive risk:  698 679 112 1080 432 100 1055 430 140 68 145 61 
H-negative risk:  679 698 1055 1080 430 432 100 112 145 140 61 68 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 88 29 

clinical_engagement 
diagnosis 
demography 
61 new agents 
246 
disease_progression 
H-positive risk:  690 675 110 1095 426 101 1055 430 143 68 147 60 
H-negative risk:  675 690 1055 1095 430 426 101 110 147 143 60 68 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 88 29 

clinical_engagement 
diagnosis 
demography 
90 new agents 
247 
disease_progression 
H-positive risk:  690 674 112 1103 428 102 1055 420 143 67 147 59 
H-negative risk:  674 690 1055 1103 420 428 102 112 147 143 59 67 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 85 28 

clinical_engagement 
diagnosis 
demography 
86 new agents 
248 
disease_progression 
H-positive risk:  688 671 109 1102 435 103 1056 427 141 65 142 61 
H-negative risk:  671 688 1056 1102 427 435 103 109 142 141 61 65 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 88 27 

clinical_engagement 
diagnosis 
demography 
79 new agents 
249 
disease_progression 
H-positive risk:  691 667 108 1100 430 101 1058 428 143 65 146 63 
H-negative risk:  667 691 1058 1100 428 430 101 108 146 143 63 65 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 89 27 

clinical_engagement 
diagnosis 
demography 
72 new agents 
250 
disease_progression 
H-positive risk:  693 666 108 1097 435 101 1054 431 143 66 143 63 
H-negative risk:  666 693 1054 1097 431 435 101 108 143 143 63 66 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 90 26 

clinical_engagement 
diagnosis 
demography 
85 new agents 
251 
disease_progression 
H-positive risk:  700 675 106 1104 424 102 1042 430 146 63 146 62 
H-negative risk:  675 700 1042 1104 430 424 102 106 146 146 62 63 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
85 new agents 
252 
disease_progression 
H-positive risk:  696 674 102 1100 434 102 1045 421 150 61 149 66 
H-negative risk:  674 696 1045 1100 421 434 102 102 149 150 66 61 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
253 
disease_progression 
H-positive risk:  690 679 102 1097 429 101 1049 424 151 61 148 69 
H-negative risk:  679 690 1049 1097 424 429 101 102 148 151 69 61 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 93 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
254 
disease_progression 
H-positive risk:  686 685 99 1102 429 99 1044 426 150 61 149 70 
H-negative risk:  685 686 1044 1102 426 429 99 99 149 150 70 61 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
79 new agents 
255 
disease_progression 
H-positive risk:  687 686 101 1103 417 99 1055 429 151 58 145 69 
H-negative risk:  686 687 1055 1103 429 417 99 101 145 151 69 58 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
256 
disease_progression 
H-positive risk:  692 694 100 1089 426 98 1057 425 152 54 144 69 
H-negative risk:  694 692 1057 1089 425 426 98 100 144 152 69 54 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 94 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
257 
disease_progression 
H-positive risk:  698 683 104 1092 432 97 1059 419 151 56 140 69 
H-negative risk:  683 698 1059 1092 419 432 97 104 140 151 69 56 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 92 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
258 
disease_progression 
H-positive risk:  698 695 106 1073 432 95 1062 424 155 55 136 69 
H-negative risk:  695 698 1062 1073 424 432 95 106 136 155 69 55 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 91 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
259 
disease_progression 
H-positive risk:  697 693 107 1071 425 98 1067 430 149 56 136 71 
H-negative risk:  693 697 1067 1071 430 425 98 107 136 149 71 56 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 93 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
260 
disease_progression 
H-positive risk:  702 691 102 1089 420 98 1065 424 146 55 139 69 
H-negative risk:  691 702 1065 1089 424 420 98 102 139 146 69 55 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 96 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
261 
disease_progression 
H-positive risk:  706 691 103 1101 419 100 1053 424 143 56 135 69 
H-negative risk:  691 706 1053 1101 424 419 100 103 135 143 69 56 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 92 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
262 
disease_progression 
H-positive risk:  711 688 105 1114 411 100 1050 419 145 53 133 71 
H-negative risk:  688 711 1050 1114 419 411 100 105 133 145 71 53 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 96 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
263 
disease_progression 
H-positive risk:  715 692 101 1118 401 98 1052 416 148 55 133 71 
H-negative risk:  692 715 1052 1118 416 401 98 101 133 148 71 55 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 96 24 

clinical_engagement 
diagnosis 
demography 
87 new agents 
264 
disease_progression 
H-positive risk:  710 689 101 1111 405 93 1065 410 151 56 137 72 
H-negative risk:  689 710 1065 1111 410 405 93 101 137 151 72 56 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 92 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
265 
disease_progression 
H-positive risk:  719 697 102 1111 396 94 1057 413 151 55 137 68 
H-negative risk:  697 719 1057 1111 413 396 94 102 137 151 68 55 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 93 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
266 
disease_progression 
H-positive risk:  730 695 101 1111 395 93 1054 413 148 55 136 69 
H-negative risk:  695 730 1054 1111 413 395 93 101 136 148 69 55 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 96 23 

clinical_engagement 
diagnosis 
demography 
62 new agents 
267 
disease_progression 
H-positive risk:  720 700 102 1110 394 92 1058 418 147 57 135 67 
H-negative risk:  700 720 1058 1110 418 394 92 102 135 147 67 57 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 97 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
268 
disease_progression 
H-positive risk:  713 699 104 1105 396 89 1072 414 149 57 137 65 
H-negative risk:  699 713 1072 1105 414 396 89 104 137 149 65 57 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 98 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
269 
disease_progression 
H-positive risk:  712 702 103 1104 390 91 1070 419 148 56 140 65 
H-negative risk:  702 712 1070 1104 419 390 91 103 140 148 65 56 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 92 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
270 
disease_progression 
H-positive risk:  711 705 101 1108 389 91 1067 419 145 59 139 66 
H-negative risk:  705 711 1067 1108 419 389 91 101 139 145 66 59 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 91 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
271 
disease_progression 
H-positive risk:  710 704 98 1111 390 90 1069 421 144 56 142 65 
H-negative risk:  704 710 1069 1111 421 390 90 98 142 144 65 56 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 89 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
272 
disease_progression 
H-positive risk:  707 701 101 1114 399 88 1054 423 148 59 142 64 
H-negative risk:  701 707 1054 1114 423 399 88 101 142 148 64 59 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
273 
disease_progression 
H-positive risk:  709 695 103 1112 399 85 1053 427 149 59 145 64 
H-negative risk:  695 709 1053 1112 427 399 85 103 145 149 64 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
274 
disease_progression 
H-positive risk:  706 687 105 1120 401 85 1057 429 152 56 140 62 
H-negative risk:  687 706 1057 1120 429 401 85 105 140 152 62 56 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
275 
disease_progression 
H-positive risk:  703 685 108 1112 404 89 1064 420 155 54 143 63 
H-negative risk:  685 703 1064 1112 420 404 89 108 143 155 63 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
276 
disease_progression 
H-positive risk:  703 680 108 1111 404 89 1069 421 156 54 141 64 
H-negative risk:  680 703 1069 1111 421 404 89 108 141 156 64 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
277 
disease_progression 
H-positive risk:  709 680 110 1107 402 91 1066 425 156 54 138 62 
H-negative risk:  680 709 1066 1107 425 402 91 110 138 156 62 54 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 86 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
278 
disease_progression 
H-positive risk:  707 682 110 1108 399 89 1081 421 152 54 136 61 
H-negative risk:  682 707 1081 1108 421 399 89 110 136 152 61 54 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
91 new agents 
279 
disease_progression 
H-positive risk:  700 680 109 1115 385 91 1094 421 154 52 138 61 
H-negative risk:  680 700 1094 1115 421 385 91 109 138 154 61 52 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
280 
disease_progression 
H-positive risk:  699 672 109 1114 380 92 1097 427 155 53 140 62 
H-negative risk:  672 699 1097 1114 427 380 92 109 140 155 62 53 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
281 
disease_progression 
H-positive risk:  689 672 109 1113 379 94 1104 429 158 52 139 62 
H-negative risk:  672 689 1104 1113 429 379 94 109 139 158 62 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 81 26 

clinical_engagement 
diagnosis 
demography 
79 new agents 
282 
disease_progression 
H-positive risk:  687 669 104 1120 382 96 1099 440 155 50 137 61 
H-negative risk:  669 687 1099 1120 440 382 96 104 137 155 61 50 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
84 new agents 
283 
disease_progression 
H-positive risk:  695 665 104 1120 378 99 1098 437 158 50 139 57 
H-negative risk:  665 695 1098 1120 437 378 99 104 139 158 57 50 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
56 new agents 
284 
disease_progression 
H-positive risk:  693 660 99 1115 383 102 1098 442 160 48 141 59 
H-negative risk:  660 693 1098 1115 442 383 102 99 141 160 59 48 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
87 new agents 
285 
disease_progression 
H-positive risk:  693 650 99 1112 384 108 1097 447 159 48 141 62 
H-negative risk:  650 693 1097 1112 447 384 108 99 141 159 62 48 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
286 
disease_progression 
H-positive risk:  695 648 100 1116 381 108 1102 441 159 50 139 61 
H-negative risk:  648 695 1102 1116 441 381 108 100 139 159 61 50 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
287 
disease_progression 
H-positive risk:  682 653 102 1123 380 106 1102 444 160 51 135 62 
H-negative risk:  653 682 1102 1123 444 380 106 102 135 160 62 51 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
288 
disease_progression 
H-positive risk:  679 661 105 1128 378 108 1098 429 162 54 135 63 
H-negative risk:  661 679 1098 1128 429 378 108 105 135 162 63 54 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
289 
disease_progression 
H-positive risk:  680 660 104 1129 376 109 1091 433 160 57 137 64 
H-negative risk:  660 680 1091 1129 433 376 109 104 137 160 64 57 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
290 
disease_progression 
H-positive risk:  672 655 104 1140 381 112 1094 428 160 54 137 63 
H-negative risk:  655 672 1094 1140 428 381 112 104 137 160 63 54 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
64 new agents 
291 
disease_progression 
H-positive risk:  674 652 104 1142 385 113 1093 425 157 55 139 61 
H-negative risk:  652 674 1093 1142 425 385 113 104 139 157 61 55 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 88 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
292 
disease_progression 
H-positive risk:  681 654 101 1140 394 111 1088 422 156 56 138 59 
H-negative risk:  654 681 1088 1140 422 394 111 101 138 156 59 56 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 88 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
293 
disease_progression 
H-positive risk:  692 655 100 1126 398 110 1086 421 158 56 137 61 
H-negative risk:  655 692 1086 1126 421 398 110 100 137 158 61 56 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 86 27 

clinical_engagement 
diagnosis 
demography 
74 new agents 
294 
disease_progression 
H-positive risk:  695 665 103 1116 392 111 1079 424 160 58 135 62 
H-negative risk:  665 695 1079 1116 424 392 111 103 135 160 62 58 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 83 28 

clinical_engagement 
diagnosis 
demography 
77 new agents 
295 
disease_progression 
H-positive risk:  699 671 102 1112 395 110 1067 430 160 55 137 62 
H-negative risk:  671 699 1067 1112 430 395 110 102 137 160 62 55 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
89 new agents 
296 
disease_progression 
H-positive risk:  704 677 104 1106 397 108 1066 423 164 56 136 59 
H-negative risk:  677 704 1066 1106 423 397 108 104 136 164 59 56 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 88 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
297 
disease_progression 
H-positive risk:  704 681 102 1098 403 111 1063 424 162 56 137 59 
H-negative risk:  681 704 1063 1098 424 403 111 102 137 162 59 56 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 88 28 

clinical_engagement 
diagnosis 
demography 
87 new agents 
298 
disease_progression 
H-positive risk:  697 683 105 1102 407 109 1066 416 163 56 135 61 
H-negative risk:  683 697 1066 1102 416 407 109 105 135 163 61 56 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 90 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
299 
disease_progression 
H-positive risk:  702 676 105 1100 416 109 1063 415 163 57 134 60 
H-negative risk:  676 702 1063 1100 415 416 109 105 134 163 60 57 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 90 28 

clinical_engagement 
diagnosis 
demography 
77 new agents 
300 
disease_progression 
H-positive risk:  702 677 103 1092 424 107 1055 418 168 60 132 62 
H-negative risk:  677 702 1055 1092 418 424 107 103 132 168 62 60 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 90 27 

clinical_engagement 
diagnosis 
demography 
88 new agents 
301 
disease_progression 
H-positive risk:  703 675 100 1096 425 104 1056 415 170 57 137 62 
H-negative risk:  675 703 1056 1096 415 425 104 100 137 170 62 57 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 90 27 

clinical_engagement 
diagnosis 
demography 
79 new agents 
302 
disease_progression 
H-positive risk:  710 670 101 1091 423 105 1058 415 174 53 139 61 
H-negative risk:  670 710 1058 1091 415 423 105 101 139 174 61 53 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 94 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
303 
disease_progression 
H-positive risk:  716 675 102 1092 419 105 1057 407 171 54 142 60 
H-negative risk:  675 716 1057 1092 407 419 105 102 142 171 60 54 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 96 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
304 
disease_progression 
H-positive risk:  708 673 103 1090 428 106 1058 409 168 53 143 61 
H-negative risk:  673 708 1058 1090 409 428 106 103 143 168 61 53 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 95 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
305 
disease_progression 
H-positive risk:  714 679 103 1091 418 106 1049 414 167 52 146 61 
H-negative risk:  679 714 1049 1091 414 418 106 103 146 167 61 52 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 95 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
306 
disease_progression 
H-positive risk:  709 678 101 1101 412 106 1055 410 169 52 143 64 
H-negative risk:  678 709 1055 1101 410 412 106 101 143 169 64 52 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 93 25 

clinical_engagement 
diagnosis 
demography 
86 new agents 
307 
disease_progression 
H-positive risk:  702 681 101 1109 409 107 1054 410 166 55 142 64 
H-negative risk:  681 702 1054 1109 410 409 107 101 142 166 64 55 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
308 
disease_progression 
H-positive risk:  699 682 102 1105 404 108 1056 411 165 61 145 62 
H-negative risk:  682 699 1056 1105 411 404 108 102 145 165 62 61 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
88 new agents 
309 
disease_progression 
H-positive risk:  688 686 103 1103 403 105 1063 419 166 57 146 61 
H-negative risk:  686 688 1063 1103 419 403 105 103 146 166 61 57 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 91 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
310 
disease_progression 
H-positive risk:  693 677 106 1104 412 106 1061 414 164 58 146 59 
H-negative risk:  677 693 1061 1104 414 412 106 106 146 164 59 58 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 90 22 

clinical_engagement 
diagnosis 
demography 
84 new agents 
311 
disease_progression 
H-positive risk:  699 669 106 1112 414 107 1050 419 163 60 144 57 
H-negative risk:  669 699 1050 1112 419 414 107 106 144 163 57 60 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 92 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
312 
disease_progression 
H-positive risk:  702 678 102 1104 409 106 1054 419 163 62 146 55 
H-negative risk:  678 702 1054 1104 419 409 106 102 146 163 55 62 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 92 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
313 
disease_progression 
H-positive risk:  691 685 102 1104 409 102 1063 414 165 59 152 54 
H-negative risk:  685 691 1063 1104 414 409 102 102 152 165 54 59 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 91 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
314 
disease_progression 
H-positive risk:  689 683 102 1100 412 103 1067 412 169 57 151 55 
H-negative risk:  683 689 1067 1100 412 412 103 102 151 169 55 57 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 95 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
315 
disease_progression 
H-positive risk:  692 678 101 1105 418 102 1055 417 169 58 153 52 
H-negative risk:  678 692 1055 1105 417 418 102 101 153 169 52 58 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 94 21 

clinical_engagement 
diagnosis 
demography 
89 new agents 
316 
disease_progression 
H-positive risk:  691 679 102 1101 418 100 1071 405 167 62 149 55 
H-negative risk:  679 691 1071 1101 405 418 100 102 149 167 55 62 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 94 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
317 
disease_progression 
H-positive risk:  691 677 99 1107 415 94 1075 405 170 58 155 54 
H-negative risk:  677 691 1075 1107 405 415 94 99 155 170 54 58 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 92 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
318 
disease_progression 
H-positive risk:  694 681 100 1104 417 97 1075 400 170 56 155 51 
H-negative risk:  681 694 1075 1104 400 417 97 100 155 170 51 56 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 93 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
319 
disease_progression 
H-positive risk:  695 672 98 1114 418 99 1079 394 172 53 157 49 
H-negative risk:  672 695 1079 1114 394 418 99 98 157 172 49 53 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 92 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
320 
disease_progression 
H-positive risk:  691 671 99 1114 424 101 1089 388 165 55 156 47 
H-negative risk:  671 691 1089 1114 388 424 101 99 156 165 47 55 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 93 19 

clinical_engagement 
diagnosis 
demography 
90 new agents 
321 
disease_progression 
H-positive risk:  695 666 102 1106 422 102 1096 391 163 58 151 48 
H-negative risk:  666 695 1096 1106 391 422 102 102 151 163 48 58 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 92 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
322 
disease_progression 
H-positive risk:  700 664 103 1101 424 102 1098 387 163 59 150 49 
H-negative risk:  664 700 1098 1101 387 424 102 103 150 163 49 59 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 90 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
323 
disease_progression 
H-positive risk:  696 659 103 1113 426 102 1092 390 163 58 146 52 
H-negative risk:  659 696 1092 1113 390 426 102 103 146 163 52 58 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 92 21 

clinical_engagement 
diagnosis 
demography 
62 new agents 
324 
disease_progression 
H-positive risk:  691 662 101 1112 436 100 1101 382 161 57 148 49 
H-negative risk:  662 691 1101 1112 382 436 100 101 148 161 49 57 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 93 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
325 
disease_progression 
H-positive risk:  691 660 95 1115 433 100 1109 381 159 55 153 49 
H-negative risk:  660 691 1109 1115 381 433 100 95 153 159 49 55 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 91 24 

clinical_engagement 
diagnosis 
demography 
90 new agents 
326 
disease_progression 
H-positive risk:  688 651 95 1108 442 98 1123 379 158 54 155 49 
H-negative risk:  651 688 1123 1108 379 442 98 95 155 158 49 54 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 91 24 

clinical_engagement 
diagnosis 
demography 
81 new agents 
327 
disease_progression 
H-positive risk:  686 647 94 1110 445 100 1125 374 155 54 159 51 
H-negative risk:  647 686 1125 1110 374 445 100 94 159 155 51 54 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 94 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
328 
disease_progression 
H-positive risk:  682 646 91 1107 447 105 1131 370 154 53 162 52 
H-negative risk:  646 682 1131 1107 370 447 105 91 162 154 52 53 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 93 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
329 
disease_progression 
H-positive risk:  684 644 93 1110 450 102 1137 362 151 52 161 54 
H-negative risk:  644 684 1137 1110 362 450 102 93 161 151 54 52 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 90 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
330 
disease_progression 
H-positive risk:  682 645 92 1106 455 103 1144 360 144 54 161 54 
H-negative risk:  645 682 1144 1106 360 455 103 92 161 144 54 54 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
331 
disease_progression 
H-positive risk:  682 646 92 1102 460 104 1138 363 144 54 162 53 
H-negative risk:  646 682 1138 1102 363 460 104 92 162 144 53 54 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
332 
disease_progression 
H-positive risk:  683 655 90 1096 455 103 1149 358 146 54 159 52 
H-negative risk:  655 683 1149 1096 358 455 103 90 159 146 52 54 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
333 
disease_progression 
H-positive risk:  685 650 89 1100 450 102 1156 360 150 53 154 51 
H-negative risk:  650 685 1156 1100 360 450 102 89 154 150 51 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
61 new agents 
334 
disease_progression 
H-positive risk:  685 654 89 1082 465 103 1152 358 152 54 156 50 
H-negative risk:  654 685 1152 1082 358 465 103 89 156 152 50 54 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
87 new agents 
335 
disease_progression 
H-positive risk:  676 661 88 1077 466 101 1157 354 156 55 158 51 
H-negative risk:  661 676 1157 1077 354 466 101 88 158 156 51 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
336 
disease_progression 
H-positive risk:  675 666 87 1077 470 98 1144 362 156 58 156 51 
H-negative risk:  666 675 1144 1077 362 470 98 87 156 156 51 58 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
337 
disease_progression 
H-positive risk:  679 659 86 1078 464 97 1147 364 157 60 158 51 
H-negative risk:  659 679 1147 1078 364 464 97 86 158 157 51 60 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
338 
disease_progression 
H-positive risk:  687 665 86 1080 456 98 1135 367 159 59 159 49 
H-negative risk:  665 687 1135 1080 367 456 98 86 159 159 49 59 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
339 
disease_progression 
H-positive risk:  689 669 85 1077 454 95 1132 369 162 61 160 47 
H-negative risk:  669 689 1132 1077 369 454 95 85 160 162 47 61 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
90 new agents 
340 
disease_progression 
H-positive risk:  695 675 83 1064 459 92 1132 368 166 61 158 47 
H-negative risk:  675 695 1132 1064 368 459 92 83 158 166 47 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
88 new agents 
341 
disease_progression 
H-positive risk:  702 678 82 1057 458 92 1133 365 166 61 157 49 
H-negative risk:  678 702 1133 1057 365 458 92 82 157 166 49 61 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
342 
disease_progression 
H-positive risk:  698 670 84 1053 468 89 1135 368 167 61 157 50 
H-negative risk:  670 698 1135 1053 368 468 89 84 157 167 50 61 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
84 new agents 
343 
disease_progression 
H-positive risk:  697 669 84 1063 461 87 1131 365 173 61 160 49 
H-negative risk:  669 697 1131 1063 365 461 87 84 160 173 49 61 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
344 
disease_progression 
H-positive risk:  690 674 86 1059 459 86 1137 368 171 62 160 48 
H-negative risk:  674 690 1137 1059 368 459 86 86 160 171 48 62 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
345 
disease_progression 
H-positive risk:  695 674 87 1063 456 87 1130 372 170 58 158 50 
H-negative risk:  674 695 1130 1063 372 456 87 87 158 170 50 58 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 89 24 

clinical_engagement 
diagnosis 
demography 
61 new agents 
346 
disease_progression 
H-positive risk:  698 672 86 1066 460 88 1125 368 169 59 157 52 
H-negative risk:  672 698 1125 1066 368 460 88 86 157 169 52 59 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
82 new agents 
347 
disease_progression 
H-positive risk:  702 675 86 1051 465 93 1114 374 170 59 157 54 
H-negative risk:  675 702 1114 1051 374 465 93 86 157 170 54 59 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
91 new agents 
348 
disease_progression 
H-positive risk:  708 668 84 1058 457 90 1119 377 171 59 156 53 
H-negative risk:  668 708 1119 1058 377 457 90 84 156 171 53 59 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
349 
disease_progression 
H-positive risk:  706 667 85 1059 454 90 1128 374 170 59 158 50 
H-negative risk:  667 706 1128 1059 374 454 90 85 158 170 50 59 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
350 
disease_progression 
H-positive risk:  699 667 85 1048 461 89 1139 376 174 55 156 51 
H-negative risk:  667 699 1139 1048 376 461 89 85 156 174 51 55 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
351 
disease_progression 
H-positive risk:  700 667 85 1039 460 89 1141 383 171 57 157 51 
H-negative risk:  667 700 1141 1039 383 460 89 85 157 171 51 57 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
60 new agents 
352 
disease_progression 
H-positive risk:  696 662 87 1040 462 91 1145 380 171 57 157 52 
H-negative risk:  662 696 1145 1040 380 462 91 87 157 171 52 57 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
353 
disease_progression 
H-positive risk:  688 662 84 1040 463 92 1149 379 173 58 159 53 
H-negative risk:  662 688 1149 1040 379 463 92 84 159 173 53 58 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
85 new agents 
354 
disease_progression 
H-positive risk:  688 669 85 1037 461 95 1139 388 174 53 159 52 
H-negative risk:  669 688 1139 1037 388 461 95 85 159 174 52 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
90 new agents 
355 
disease_progression 
H-positive risk:  689 675 86 1036 451 93 1143 391 173 53 158 52 
H-negative risk:  675 689 1143 1036 391 451 93 86 158 173 52 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
356 
disease_progression 
H-positive risk:  692 674 87 1028 458 93 1142 394 172 51 153 56 
H-negative risk:  674 692 1142 1028 394 458 93 87 153 172 56 51 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
357 
disease_progression 
H-positive risk:  696 677 81 1020 463 94 1142 391 173 51 156 56 
H-negative risk:  677 696 1142 1020 391 463 94 81 156 173 56 51 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
358 
disease_progression 
H-positive risk:  696 678 81 1023 462 97 1147 385 174 50 152 55 
H-negative risk:  678 696 1147 1023 385 462 97 81 152 174 55 50 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
359 
disease_progression 
H-positive risk:  696 667 83 1024 462 98 1152 390 172 50 152 54 
H-negative risk:  667 696 1152 1024 390 462 98 83 152 172 54 50 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
90 new agents 
360 
disease_progression 
H-positive risk:  690 663 85 1032 463 98 1153 385 173 50 155 53 
H-negative risk:  663 690 1153 1032 385 463 98 85 155 173 53 50 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
85 new agents 
Time difference of 17.54438 mins
This is task 20
date
